BDD-20617

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameBDD-20617
Drug Alias Namelevodopa analogs (BiRDS)BDD-206XXBDD-20617BDD-20617-DA
ClassificationSmall molecules
Mechanisms of ActionDopamine receptors agonistsDopamine synthesis modulators
TargetsDopamine receptors
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBerolina Innovative Research and Development Services Pharma AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBerolina Innovative Research and Development Services Pharma AG
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A